Abstract
The effects of short-term (3–4 days) lithium treatment on the prolactin responses to intravenous clomipramine (0.1 mg/kg), metoclopramide (5 μg/kg) and haloperidol (2.5–5 μg/kg) were assessed in male volunteers. Prolactin responses to clomipramine were significantly enhanced by lithium while those following administration of haloperidol and metoclopramide were not significantly altered. Lithium did not change the cortisol response to clomipramine. The results suggest that lithium may selectively enhance 5-HT mediated prolactin release. These data are consistent with the hypothesis that synergistic effects of lithium and clomipramine on brain 5-HT function may be involved in their therapeutic effect in resistant depression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson IM, Cowen PJ (1986) Clomipramine enhances prolactin and growth hormone responses to l-tryptophan. Psychopharmacology 89:131–133
Carlsson A, Corrodi H, Fuxe K, Hockfelt T (1969) Effects of some antidepressant drugs on depletion of intraneuronal brain catecholamine stores caused by 4-α-dimethylmetatyramine. Eur J Pharmacol 15:367–373
Charig EM, Anderson IM, Robinson JM, Nutt DJ, Cowen PJ (1986) l-tryptophan and prolactin release: evidence for interaction between 5-HT1 and 5-HT2 receptors. Hum Psychopharmacol 1:91–97
Checkley SA (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10:35–53
Fang VS, Shian L-R (1981) A serotonergic mechanism of the prolactin stimulating action of metoclopramide. Endocrinology 108:1622–1627
Glue PW, Cowen PJ, Nutt DJ, Kolakowska T, Grahame-Smith DG (1986) The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors. Psychopharmacology 90:398–402
Goodwin GM, De Souza RJ, Wood AJ, Green AR (1986a) The enhancement by lithium of the 5-HT1A mediated syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism. Psychopharmacology 90:488–493
Goodwin GM, De Souza RJ, Wood AJ, Green AR (1986b) Lithium decreases 5-HT1A and 5-HT2 receptor and α-adrenoceptormediated function in mice. Psychopharmacology 91:500–504
Grahame-Smith DG, Green AR (1974) The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by the lithium and monoamine oxidase inhibitors. Br J Pharmacol 52:19–26
Hale AS, Proctor AW, Bridges PK (1987) Lithium in combination for resistant depression: seven case studies. Br J Psychiatry 151:213–217
Hotta I, Yamawaki S (1988) Possible involvement of presynaptic 5-HT autoreceptors in effect of lithium on 5-HT release in hippocampus of rat. Neuropharmacology 27:987–992
Joyce PR, Donald RA, Livesey JH, Abott RM (1987) The prolactin response to metaclopramide is increased in depression and in euthymic rapid cycling bipolar patients. Biol Psychiatry 22: 508–512
Jungmann E, Althoff P-H, Hermann GJ, Schoffling K (1984) The effect of pizotifen, a serotonin antagonist, and of pirenzipine, a muscarinic antagonist, on hormonal responses to metaclopramide in healthy subjects. Arzneimittelforschung 34:1022–1024
Knapp S, Mandell AJ (1973) Short-and long-term lithium administrations: effects on the brain's serotonergic biosynthetic systems. Science 180:645–647
Laakmann G, Chuang I, Gugath M, Ortner M, Schmauss M, Wittmann M (1983) Prolactin and antidepressants. In: Tolis G, Stefanis C, Mountokalakis T, Labrie F (eds) Prolactin and prolactinomas. Raven Press, New York
Laakmann G, Gugath M, Kuss H-J, Zygan K (1984a) Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desipramine in man in connection with chlorimipramine metabolism. Psychopharmacology 82:62–67
Laakmann G, Wittmann M, Gugath M, Mueller OA, Treusch TJ, Wahlster U, Stalla GK (1984b) Effects of psychotropic drugs (desipramine, chlorimipramine, sulpiride, and diazepam) on the human HPA axis. Psychopharmacology 84:66–70
Laakmann G, Schoen HW, Blaschke D, Wittmann M (1985) Dosedependent growth hormone, prolactin and cortisol stimulation after I.V. administration of desipramine in human subjects. Psychoneuroendocrinology 10:83–93
Laakmann G, Schoen H-W, Zygan K, Weiss A, Wittmann M, Meissner R (1986a) Effects of receptor blockers (methysergide, propanolol, phentolamine, yohimbine and prazosin) on desipramine-induced pituitary hormone stimulation in humans-11. Prolactin. Psychoneuroendocrinology 4:463–474
Laakmann G, Schoen H-W, Zygan K, Weiss A, Wittmann M, Meissner R, Mueller OA, Stalla GK (1986b) Effects of receptor blockers (methysergide, propanolol, phentolamine, yohimbine and prazosin) on desipramine-induced pituitary hormone stimulation in humans-111. Hypothalamo-pituitary-adrenocortical axis. Psychoneuroendocrinology 4:475–489
Lal S, Nair NPV, Guyda H (1978) Effect of lithium on hypothalamic-pituitary dopaminergic function. Acta Psychiatr Scand 57:91–96
Langer G, Sachar EJ, Halpern FS, Gruen PH, Solomons M (1977) The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: neureendocrine studies in normal men. J Clin Endocrinol Metab 45:996–1002
McCallum RW, Sowers JR, Hershman JM, Sturdevant RAL (1976) Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab 42:1148–1152
McCance SL, Cowen PJ, Waller H, Grahame-Smith DG (1987) The effect of metergoline on endocrine responses to l-tryptophan. J Psychopharmacol 2:90–94
Meltzer HY, Lowy M, Robertson A, Goodnick P, Perline R (1984) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. 111. Effects of antidepressants and lithium carbonate. Arch Gen Psychiatry 41:391–397
Mühlbauer HD, Müller-Oerlinghausen B (1985) Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotenergic action of lithium in man. J Neural Transm 61:81–94
Ross SB, Renyi AL (1975) Tricyclic antidepressant agents. 1. Comparison of the inhibition of the uptake of [3H]noradrenaline and [14C]5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol Toxicol 36:382–388
Rubin RT, Poland RE, O'Connor D, Gouin P, Tower BR (1976) Selective neuroendocrine effects of low dose haloperidol in normal adult men. Psychopharmacology 47:135–140
Rudorfer MV, Golden RN, Sherer MA, Lesieur P, Potter WZ (1986) Antidepressant challenge tests in man. In: Shagass C (ed) Proceedings of the World Congress of Biological Psychiatry. Elsevier, Amsterdam
Swann AC, Heninger GR, Roth RH, Maas JW (1981) Differential effects of short- and long-term lithium on tryptophan uptake and serotonergic function in cat brain. Life Sci 28:347–354
Treiser SL, Cascio CS, O'Donohue TL, Kellar K (1981) Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213: 1529–1531
Wang H-Y, Friedman E (1988) Chronic lithium: desensitisation of autoreceptors mediating serotonin release. Psychopharmacology 94:312–314
Wood AJ, Goodwin GM (1987) A review of the biochemical and pharmacological actions of lithium. Psychol Med 17:579–600
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCance, S.L., Cohen, P.R. & Cowen, P.J. Lithium increases 5-HT-mediated prolactin release. Psychopharmacology 99, 276–281 (1989). https://doi.org/10.1007/BF00442822
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442822